The cancer research company has adopted a digital asset treasury model centered on decentralized physical infrastructure networks.
Predictive Oncology (POAI), a biotechnology company specializing in AI-driven cancer research, has announced a $344.4 million digital asset treasury centered on Aethir’s ATH token, marking the first time a Nasdaq-listed company will hold and actively manage tokens from a Decentralized Physical Infrastructure Network (DePIN).
The capital strategy was developed with guidance from DNA Fund, a Web3 investment and advisory company, and BTIG, which served as the placement agent, Predictive Oncology disclosed Monday. It was structured as two concurrent private placements in public equity (PIPEs), combining cash investment with a crypto PIPE involving in-kind contributions of ATH tokens, DNA Fund said in a separate announcement.
The structure allows Predictive Oncology to record tokenized DePIN infrastructure as a balance sheet asset, introducing a hybrid financing model that connects traditional equity markets with decentralized computing networks. The ATH treasury will be tied directly to Aethir’s decentralized GPU infrastructure.
